Ikhithi yokuxilonga ye-25-hydroxy Vitamin D(uvavanyo lwe-fluorescence immunochromatographic)
Ukusetyenziswa kwe-in vitro diagnostic kuphela
Nceda ufunde le phakheji ifake ngononophelo phambi kokuba uyisebenzise kwaye ulandele ngokungqongqo imiyalelo. Ukuthembeka kweziphumo zovavanyo akunakuqinisekiswa ukuba kukho nakuphi na ukutenxa kwimiyalelo ekweli phakheji.

UKUSETYENZISWA OKUHLOSIWEYO
Ikhithi yokuxilonga ye-25-hydroxy iVithamin D (i-fluorescence immunochromatographic assay) luvavanyo lwe-fluorescence immunochromatographic yokufumanisa ubungakanani be-25-hydroxy Vitamin D (25-(OH) VD) kwiserum yabantu okanye iplasma, esetyenziswa ikakhulu ukuvavanya amanqanaba. yevithamin D.Sisixhobo esincedisayo sokuxilongwa.Yonke isampulu kufuneka iqinisekiswe ngezinye iindlela. Olu vavanyo lwenzelwe ukusetyenziswa kweengcali zezempilo kuphela.

USHWANKATHELO
I-Vitamin D yivithamin kwaye ikwayi-hormone ye-steroid, ingakumbi i-VD2 kunye ne-VD3, umyalelo wayo ufana kakhulu. I-Vitamin D3 kunye ne-D2 iguqulwa ibe yi-25 i-hydroxyl i-vitamin D (kuquka i-25-dihydroxyl i-vitamin D3 kunye ne-D2). I-25-(OH) i-VD emzimbeni womntu, umyalelo ozinzileyo, ukugxila okuphezulu. I-25-(OH) i-VD ibonisa inani elipheleleyo levithamini D, kunye nokukwazi ukuguqulwa kwe-vitamin D, ngoko i-25-(OH) VD ithathwa njengesona salathisi sokuvavanya izinga le-vitamin D.I-Diagnostic Kit isekelwe i-immunochromatography kwaye inokunika umphumo kwimizuzu eyi-15.

UMGAQO WENKQUBO
I-membrane yesixhobo sokuvavanya ifakwe kwi-conjugate ye-BSA kunye ne-25- (OH) VD kwindawo yokuvavanya kunye nebhokhwe yokulwa nomvundla we-IgG kwingingqi yokulawula. Iphedi yokumakisha iqatywe nge-fluorescence mark anti-25-(OH) VD antibody kunye nomvundla IgG kwangaphambili. Xa uvavanyo lwesampulu, 25-(OH) VD kwisampulu dibanisa fluorescence iphawulwe anti 25-(OH) VD antibody, kwaye wenze umxube omzimba. Ngaphantsi kwesenzo se-immunochromatography, ukuhamba okuyinkimbinkimbi kwicala lephepha elifunxayo, xa i-complex idlula ummandla wokuvavanya, I-marker ye-fluorescent yamahhala iya kudibaniswa ne-25-(OH) VD kwi-membrane.Uxinzelelo lwe-25-(OH) I-VD lulungelelwaniso olubi lwesignali ye-fluorescence, kunye noxinaniso lwe-25-(OH) VD kwisampulu lunokubonwa nge-fluorescence immunoassay assay.

IIREGENTS KUNYE NEZINTO EZIBONISWAYO

Amacandelo ephakheji ye-25T:
.Ikhadi lovavanyo lwefoyile nganye efakwe kwi-desiccant 25T
.Isisombululo 25T
.B isisombululo 1
.Fakela ipakethe 1

IZINTO EZIFUNEKAYO KODWA AKUNIKEZWA
Isampulu yokuqokelela isitya,ixesha

UKUQOKELELWA KWEsampuli NOKUGCINWA
1.Iisampulu ezivavanyiweyo zingaba serum, i-heparin anticoagulant plasma okanye i-EDTA anticoagulant plasma.
2.Ngokungqinelana neendlela eziqhelekileyo zokuqokelela isampuli. I-Serum okanye isampuli ye-plasma inokugcinwa efrijini kwi-2-8 ℃ ye-7days kunye ne-cryopreservation engaphantsi kwe-15 ° C kwiinyanga ezi-6.
3.Zonke iisampulu ziphephe imijikelo yokunyibilika komkhenkce.

INKQUBO YOVAVANYO
Inkqubo yovavanyo yesixhobo bona incwadana ye-immunoanalyzer. Inkqubo yovavanyo lwe-reagent ngolu hlobo lulandelayo
I-1.Lay eceleni zonke ii-reagents kunye neesampuli kwiqondo lokushisa.
2.Vula i-Portable Immune Analyzer (WIZ-A101), faka igama lokungena kwi-akhawunti ngokwendlela yokusebenza yesixhobo, kwaye ungenise ujongano lokubona.
3.Skena ikhowudi yokuchaza ukuze uqinisekise into yovavanyo.
4.Khupha ikhadi lovavanyo kwibhegi yefoyile.
5.Faka ikhadi lovavanyo kwi-slot yekhadi, scan ikhowudi ye-QR, kwaye unqume into yovavanyo.
6.Yongeza i-30μL serum okanye isampuli yeplasma kwisisombululo, kwaye udibanise kakuhle.
7.Yongeza isisombululo se-50μL B kumxube ongentla, kwaye udibanise kakuhle.
8.Shiya umxube imizuzu eyi-15.
9.Yongeza i-80μL umxube kwisampulu yequla lekhadi.
10.Klikha iqhosha elithi "standard test",emva kwemizuzu eyi-10, isixhobo siya kubona ngokuzenzekelayo ikhadi lovavanyo, sinako ukufunda iziphumo kwiscreen sesikrini sesixhobo, kwaye sirekhode/siprinte iziphumo zovavanyo.
11.Jonga kumyalelo we-Portable Immune Analyzer (WIZ-A101).

IINDLELA EZILINDELEKILEYO
I-25-(OH) VD uluhlu oluqhelekileyo: 30-100ng / mL
Kucetyiswa ukuba ilabhoratri nganye iseke uluhlu lwayo oluqhelekileyo olumele izigulane zayo.

IZIPHUMO ZOMVAVANYO KUNYE UTOLIKO
.Le datha ingentla lithuba lereferensi elisekwe kwidatha yobhaqo yale khithi, kwaye kucetyiswa ukuba ilabhoratri nganye kufuneka iseke isithuba sesalathiso sokubaluleka kwezonyango olufanelekileyo lwabemi kulo mmandla.
.I-concentration ye-25-(OH) VD iphezulu kunoluhlu lwereferensi, kwaye utshintsho lwe-physiological okanye impendulo yoxinzelelo kufuneka ingabandakanywa.Ngokuqinisekileyo ingaqhelekanga, kufuneka idibanise ukuxilongwa kweempawu zeklinikhi.
.Iziphumo zale ndlela zisebenza kuphela kuluhlu lwereferensi olusekwe yile ndlela, kwaye iziphumo azifani ngokuthe ngqo nezinye iindlela.
.Ezinye izinto zinokubangela iimpazamo kwiziphumo zokubona, kubandakanywa nezizathu zobugcisa, iimpazamo zokusebenza kunye nezinye izinto zesampulu.

UKUGCINWA NOZINZI
.Ikhithi ziinyanga ezili-18 zobomi beshelufa ukusukela kumhla wokwenziwa kwayo. Gcina iikhithi ezingasetyenziswanga kwi-2-30°C. MUSA UKUMKHENZA. Musa ukusebenzisa ngaphaya komhla wokuphelelwa.
.Musa ukuvula isingxobo esitywiniweyo de ube ulungele ukwenza uvavanyo, kwaye uvavanyo lokusetyenziswa olunye lucetyiswa ukuba lusetyenziswe phantsi kwendawo efunekayo (iqondo lobushushu 2-35℃, ukufuma 40-90%) ngaphakathi kwemizuzu engama-60 ngokukhawuleza. kunokwenzeka.
.I-diluent yesampuli isetyenziswa ngoko nangoko emva kokuvulwa.

IZILUMKISO NEMIGAQO
.Ikhithi kufuneka itywinwe kwaye ikhuselwe kumswakama.
.Yonke imizekelo emihle iya kuqinisekiswa ngezinye iindlela.
.Yonke imizekelo iya kuphathwa njengongcoliseko olunokubakho.
.USUKU sebenzisa i-reagent ephelelwe lixesha.
. MUSA ukutshintshiselana ngeerejenti phakathi kweekhithi ezinenombolo eyahlukileyo.
.USUKU phinda usebenzise amakhadi ovavanyo kunye naziphi na izincedisi ezilahlwayo.
.I-Misoperation, isampuli eninzi okanye encinci inokukhokelela ekuphambukeni kweziphumo.

LUKUXELELA
.Njengalo naluphi na uvavanyo olusebenzisa izilwa-buhlungu zegundane, kunokwenzeka ukuba kukho ukuphazanyiswa yi-anti-mouse antibodies (HAMA) kwi-specimen. Iisampulu ezisuka kwizigulane ezifumene amalungiselelo ee-antibodies ze-monoclonal zokuxilongwa okanye unyango zingaquka i-HAMA. Imizekelo enjalo inokubangela ubuxoki okanye iziphumo ezingalunganga.
.Esi siphumo sovavanyo kuphela kwireferensi yeklinikhi, akufanele sisebenze njengesiseko kuphela sokuxilongwa kweklinikhi kunye nonyango, izigulane zolawulo lwezonyango kufuneka ziqwalaselwe ngokubanzi kunye neempawu zayo, imbali yonyango, ezinye iimviwo zebhubhoratri, impendulo yonyango, i-epidemiology kunye nolunye ulwazi. .
.Le reagent isetyenziselwa kuphela iimvavanyo ze-serum kunye ne-plasma. Isenokungafumani ziphumo zichanekileyo xa isetyenziselwa ezinye iisampulu ezinje ngamathe nomchamo, njl.

IIMPAWU ZOKUSEBENZA

RIMIZEKELO

1.Hansen JH, et al.HAMA Ukuphazamiseka kunye ne-Murine Monoclonal Antibody-Based Immunoassays [J] .J ye-Clin Immunoassay, 1993, 16: 294-299.
2.Levinson SS.Ubume be-Heterophilic Antibodies kunye nendima kwi-Immunoassay Interference[J].J ye-Clin Immunoassay,1992,15:108-114.

Isitshixo kwiisimboli ezisetyenzisiweyo:

	In Vitro Diagnostic Medical Isixhobo
	Umenzi
	Gcina kwi-2-30 ℃
	Umhla WOKUPHELELWA
	Musa Ukuphinda Usebenzise
	ISILUMKO
	Qhagamshelana neMiyalelo yokuSetyenziswa

Xiamen Wiz Biotech CO.,LTD
Idilesi: 3-4 Floor,NO.16 Building,Bio-medical Workshop,2030 Wengjiao West Road,Haicang District,361026,Xiamen,China
Umnxeba: + 86-592-6808278
Ifeksi: + 86-592-6808279